5th Circ. Finds Chemo Drug Hair Loss Claims Filed Too Late

By Mike Curley (April 22, 2021, 1:34 PM EDT) -- The Fifth Circuit has thrown out a pair of suits against Sanofi U.S. Services Inc. alleging it failed to warn women that its chemotherapy drug Taxotere could cause permanent hair loss, finding the plaintiffs should have looked sooner into the cause of their injury.

In an opinion filed late Wednesday, the three-judge panel found the three plaintiffs in the suits, Deborah Johnson, Tanya Francis and Cynthia Thibodeaux, did not exercise due diligence and thus could not toll their claims against Sanofi past Louisiana's one-year statutory limits.

While the women had argued they did not have information to implicate Sanofi until just...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!